BlackRock Health Sciences Trust (NYSE:BME – Get Free Report) saw a significant drop in short interest in March. As of March 13th, there was short interest totaling 67,055 shares, a drop of 17.4% from the February 26th total of 81,198 shares. Based on an average daily volume of 45,079 shares, the days-to-cover ratio is presently 1.5 days.
Institutional Inflows and Outflows
Several large investors have recently modified their holdings of BME. Northwestern Mutual Wealth Management Co. lifted its position in BlackRock Health Sciences Trust by 22.2% during the third quarter. Northwestern Mutual Wealth Management Co. now owns 1,417 shares of the company’s stock valued at $53,000 after acquiring an additional 257 shares during the last quarter. SOA Wealth Advisors LLC. increased its position in shares of BlackRock Health Sciences Trust by 20.3% during the third quarter. SOA Wealth Advisors LLC. now owns 2,780 shares of the company’s stock worth $103,000 after purchasing an additional 469 shares in the last quarter. Geneos Wealth Management Inc. increased its position in BlackRock Health Sciences Trust by 200.0% during the 2nd quarter. Geneos Wealth Management Inc. now owns 4,899 shares of the company’s stock valued at $179,000 after buying an additional 3,266 shares in the last quarter. Sage Investment Counsel LLC acquired a new position in shares of BlackRock Health Sciences Trust during the third quarter valued at about $201,000. Finally, Truist Financial Corp acquired a new position in BlackRock Health Sciences Trust during the 3rd quarter valued at approximately $205,000.
BlackRock Health Sciences Trust Trading Up 0.1%
BME opened at $37.70 on Monday. The business’s 50-day moving average is $41.28 and its two-hundred day moving average is $40.05. BlackRock Health Sciences Trust has a 1 year low of $34.18 and a 1 year high of $42.74.
BlackRock Health Sciences Trust Announces Dividend
About BlackRock Health Sciences Trust
BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.
Featured Stories
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.
